HKD 8.81
(2.44%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 65.64 Million USD | -59.96% |
2022 | 161.85 Million USD | 12.13% |
2021 | 144.35 Million USD | 45.66% |
2020 | 99.09 Million USD | 67.51% |
2019 | 59.16 Million USD | 55.79% |
2018 | 37.97 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 11.36 Million USD | -20.8% |
2024 Q2 | 11.36 Million USD | 0.0% |
2023 Q4 | 14.34 Million USD | -6.91% |
2023 Q2 | 17.86 Million USD | 0.0% |
2023 Q3 | 15.4 Million USD | -13.74% |
2023 FY | 64.8 Million USD | -59.96% |
2023 Q1 | 17.86 Million USD | -54.55% |
2022 FY | 161.85 Million USD | 12.13% |
2022 Q4 | 39.29 Million USD | 0.0% |
2022 Q3 | 39.29 Million USD | -21.28% |
2022 Q2 | 49.91 Million USD | 0.0% |
2022 Q1 | 49.91 Million USD | 26.7% |
2021 Q4 | 39.4 Million USD | 0.0% |
2021 Q3 | 39.4 Million USD | 20.69% |
2021 Q1 | 32.64 Million USD | -74.57% |
2021 FY | 144.35 Million USD | 45.66% |
2021 Q2 | 32.64 Million USD | 0.0% |
2020 Q4 | 128.37 Million USD | 0.0% |
2020 Q2 | 27.14 Million USD | 0.0% |
2020 Q1 | 27.14 Million USD | 55.61% |
2020 FY | 99.09 Million USD | 67.51% |
2020 Q3 | 128.37 Million USD | 372.98% |
2019 Q3 | 17.44 Million USD | -8.25% |
2019 FY | 59.16 Million USD | 55.79% |
2019 Q4 | 17.44 Million USD | 0.0% |
2019 Q2 | 19.01 Million USD | 0.0% |
2019 Q1 | 19.01 Million USD | 0.0% |
2018 FY | 37.97 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Uni-Bio Science Group Limited | 325.05 Million HKD | 79.806% |
CK Life Sciences Int'l., (Holdings) Inc. | 739.25 Million HKD | 91.121% |